Company profile: OpenEye
1.1 - Company Overview
Company description
- Provider of computational molecular design software and services, including the Orion Molecular Design Platform for cloud-based design and simulation (virtual screening, molecular dynamics, free energy predictions, quantum mechanics, sequence analysis), large-scale 2D/3D virtual screening, lead discovery and optimization, antibody discovery, and drug formulation; with strengths in 3D molecular shape and electrostatics analysis.
Products and services
- Lead Discovery: Computational workflow that identifies new biologically active chemical matter as potential leads by visualizing and analyzing molecular 3D shape and electrostatics within drug discovery programs
- Large Scale Virtual Screening: Large-scale system searching billions of molecules across different chemical libraries using 2D and 3D virtual screening solutions
- Orion® Molecular Design Platform: Cloud-based platform delivering virtual screening, molecular dynamics, free energy predictions, quantum mechanics calculations, and sequence analysis for rapid, robust, scalable molecular design and simulation
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to OpenEye
Curio Bioscience
HQ: United States
Website
- Description: Provider of spatial transcriptomics tools for cancer biology, developmental biology, immunology, and neuroscience: Curio Seeker kits for whole transcriptome mapping of fresh-frozen tissues, compatible with eukaryotes and fitting sequencing workflows without specialized equipment; Curio Trekker for single-cell spatial mapping without deconvolution or segmentation; and the Seeker bioinformatics pipeline to process FASTQ into spatial maps.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Curio Bioscience company profile →
DL Santé
HQ: France
Website
- Description: Provider of medical technological solutions, offering quality management software and inventory calculation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full DL Santé company profile →
Quantitative Medicine
HQ: United States
Website
- Description: Provider of an in silico predictive modeling platform, Computational Research Engine (CoRE), for constructing, assessing, validating, and deploying highly accurate predictive models to efficiently guide testing and solve complex drug discovery optimization problems.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Quantitative Medicine company profile →
Evozyne
HQ: United States
Website
- Description: Provider of generative AI-driven protein design and engineering solutions for therapeutic discovery and drug development, including ProT-VAE (co-developed with NVIDIA) to design therapeutic proteins, protein engineering for rare diseases (in partnership with Takeda), evolutionary deep learning to create novel proteins, and computational chemistry to optimize protein stability and function.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Evozyne company profile →
StudyKIK
HQ: United States
Website
- Description: Provider of patient recruitment and retention technology for clinical trials, connecting trial companies with volunteers and offering KIKsite for data management and communication, Virtual Visits, CarePackage integrating telemedicine and eConsent, PatientEngage+ for enrollment and engagement, and SupportHub for outreach, appointment reminders, and transportation coordination.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full StudyKIK company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for OpenEye
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to OpenEye
2.2 - Growth funds investing in similar companies to OpenEye
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for OpenEye
4.2 - Public trading comparable groups for OpenEye
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →